Periostin-mediated activation of NF-κB signaling promotes tumor progression and chemoresistance in glioblastoma
Abstract Glioblastoma (GBM) is the most aggressive form of diffuse glioma, characterized by high lethality. Temozolomide (TMZ)-based chemotherapy is a standard treatment for GBM, but development of chemoresistance poses a significant therapeutic challenge. Despite advances in understanding GBM biolo...
Saved in:
| Main Authors: | Yu Shang, Yuxia Liang, Beichen Zhang, Wei Wu, Yihao Peng, Jin Wang, Ming Zhang, Chen Niu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-92969-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glycosylated Delphinidins Decrease Chemoresistance to Temozolomide by Regulating NF-κB/MGMT Signaling in Glioblastoma
by: Diego Carrillo-Beltrán, et al.
Published: (2025-01-01) -
PDGF‐D Promotes Epithelial–Mesenchymal Transition of Glioma Cells Through the NF‐κB/NOTCH1 Pathway
by: Yao Li, et al.
Published: (2025-06-01) -
Spatial transcriptomics and multi-omics reveal relapse and resistance mechanisms of EndMT-derived CAFs mediated by TNC and FLNC in glioblastoma
by: Li Ji, et al.
Published: (2025-07-01) -
Quercetin ameliorates epithelial-mesenchymal transition and inflammation by targeting FSTL1 and modulating the NF-κB pathway in pulmonary fibrosis
by: Yuejiao Lan, et al.
Published: (2025-07-01) -
CSRP2 promotes the glioblastoma mesenchymal phenotype via p130Cas-mediated NF-κB and MAPK pathways
by: Jiawei He, et al.
Published: (2025-08-01)